Natriuretic Peptides as Markers of Left Ventricular Reverse Remodeling After Angiotensin Receptor-Neprilysin Inhibitor Therapy

被引：0
|
作者：
Nakanishi, Koki [1 ,2 ,3 ]
Morita, Hiroyuki [1 ]
机构：
[1] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan
[2] Univ Tokyo, Dept Clin Lab, Tokyo, Japan
[3] Univ Tokyo, Dept Cardiovasc Med & Clin Lab, 7-3-1 Hongo Bunkyo Ku, Tokyo 1138655, Japan
来源：
INTERNATIONAL HEART JOURNAL | 2023年 / 64卷 / 06期
关键词：
CHRONIC HEART-FAILURE; SACUBITRIL/VALSARTAN;
D O I：
10.1536/ihj.23-525
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：967 / 969
页数：3
相关论文
共 50 条
  • [41] Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence
    Choi, Hong-Mi
    Shin, Mi-Seung
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (03): : 498 - 513
  • [42] Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction
    Nishikimi, T
    Kojima, S
    Kuramochi, M
    Takishita, S
    Yoshitomi, Y
    Kangawa, K
    Matsuo, H
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1998, 64 (02) : 153 - 160
  • [43] Angiotensin Receptor-Neprilysin Inhibition Improves Blood Pressure and Heart Failure Control in Left Ventricular Assist Device Patients
    Goldberg, Rachel L.
    Freed, Kristin E.
    Klemans, Nancy
    Fioretti, Rebecca
    Choi, Chun W.
    Kilic, Ahmet
    Adamo, Luigi
    Florido, Roberta
    Sharma, Kavita
    Gilotra, Nisha A.
    Hsu, Steven
    ASAIO JOURNAL, 2021, 67 (12) : E207 - E210
  • [44] ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR SUPPRESSED CARDIAC DYSFUNCTION BY ANGIOGENESIS IN MICE MODEL OF ATHEROSCLEROSIS
    Suematsu, Yasunori
    Ideishi, Akihito
    Tashiro, Kohei
    Miura, Shin-Ichiro
    JOURNAL OF HYPERTENSION, 2021, 39 : E191 - E191
  • [45] A clinical experience of Indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [ARNI] on an outpatient basis
    Jariwala, Pankaj
    Punjani, Arshad
    Boorugu, Harikishan
    Madhawar, Dilip Babu
    INDIAN HEART JOURNAL, 2021, 73 (02) : 211 - 213
  • [46] Angiotensin receptor-neprilysin inhibitor delays progression from paroxysmal to persistent atrial fibrillation
    Youzheng Dong
    Zhenyu Zhai
    Jihong Wang
    Zhen Xia
    Zirong Xia
    Bo Zhu
    Quanbing Dong
    Qing Li
    Juxiang Li
    Scientific Reports, 13
  • [47] Angiotensin Receptor-Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure
    Boehmer, Andreas A.
    Schubert, Tim
    Rothe, Moritz
    Keim, Christoph
    Wiedenmann, Lilli
    Ruckes, Christian
    von Stuelpnagel, Lukas
    Theurl, Fabian
    Schreinlechner, Michael
    Dobre, Bianca C.
    Kaess, Bernhard M.
    Bauer, Axel
    Ehrlich, Joachim R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (15):
  • [48] Impact of the angiotensin receptor-neprilysin inhibitor in clinical diabetes management: Potential benefits and pitfalls
    Kato, Tomoko
    Murakami, Takaaki
    Yabe, Daisuke
    Harada, Norio
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (09) : 1038 - 1040
  • [49] Angiotensin receptor-neprilysin inhibitor delays progression from paroxysmal to persistent atrial fibrillation
    Dong, Youzheng
    Zhai, Zhenyu
    Wang, Jihong
    Xia, Zhen
    Xia, Zirong
    Zhu, Bo
    Dong, Quanbing
    Li, Qing
    Li, Juxiang
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [50] Angiotensin receptor-neprilysin inhibitor adherence and outcomes in heart failure with reduced ejection fraction
    Cho, Dong-Hyuk
    Choi, Jimi
    Youn, Jong-Chan
    Kim, Mi-Na
    Lee, Chan Joo
    Son, Jung-Woo
    Yoo, Byung-Su
    ESC HEART FAILURE, 2025, 12 (01): : 603 - 612
12345